2014
DOI: 10.1007/s00280-014-2519-4
|View full text |Cite
|
Sign up to set email alerts
|

Determining the mechanisms of lapatinib-induced diarrhoea using a rat model

Abstract: In our novel rat model of lapatinib-induced diarrhoea we have shown that changes in small intestinal morphometry and expression of EGFR are associated with diarrhoea. Further research is required to test intervention agents for the prevention of diarrhoea.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
16
3

Year Published

2015
2015
2019
2019

Publication Types

Select...
4
3
1

Relationship

3
5

Authors

Journals

citations
Cited by 27 publications
(24 citation statements)
references
References 28 publications
2
16
3
Order By: Relevance
“…In a previous rat model of lapatinib‐induced diarhroea, blood biochemistry showed a significant decrease in serum chloride. This decrease coincided with diarrhoea in rats treated with high‐dose lapatinib, suggesting a possible secretory diarrhoea phenotype . However, in the current study we saw no changes in serum chloride suggesting negligible secretory processes.…”
Section: Discussioncontrasting
confidence: 40%
“…In a previous rat model of lapatinib‐induced diarhroea, blood biochemistry showed a significant decrease in serum chloride. This decrease coincided with diarrhoea in rats treated with high‐dose lapatinib, suggesting a possible secretory diarrhoea phenotype . However, in the current study we saw no changes in serum chloride suggesting negligible secretory processes.…”
Section: Discussioncontrasting
confidence: 40%
“…No significant changes were noted in intestinal weights and no significant histopathology was noted in the jejunum or colon, indicating that no significant pathology in the intestines occurred as a result of lapatinib treatment [51]. In fact, it was found that jejunum crypts were significantly longer, and contained increased mitotic cells in rats treated with lapatinib [52]. This is in stark contrast to what is noted in mucositis models of rats treated with chemotherapeutic agents such as irinotecan causing severe intestinal damage and atrophy [14,53].…”
Section: Erbb Tkis and Diarrhoeamentioning
confidence: 78%
“…This is therefore highly suggestive that the mechanism of ErbB TKI-induced diarrhoea is profoundly different from chemotherapy-induced diarrhoea. Further investigation found that serum biochemistry levels of chloride were decreased in rats treated with high dose lapatinib, correlating with diarrhoea incidence, suggesting that chloride loss via the intestinal lumen may be involved in the manifestation of small molecule ErbB TKI induced diarrhoea [52]. However, this was inconclusive.…”
Section: Erbb Tkis and Diarrhoeamentioning
confidence: 97%
“…34 Furthermore, there were alterations in electrolytes, and a lengthened crypt compartment in the jejunum in a rat lapatinib-induced diarrhoea model. 35 Compromising alterations in the villus–crypt structure are common in weaned pigs. Consistent with previous experiments, our current findings showed that intestine VH was significantly lower and that CD was increased in stress diarrhoea mice compared to control animals.…”
Section: Discussionmentioning
confidence: 99%